Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (NCT07213713) titled 'Evaluation of Anti-Xa Activity in Patients With Severe Obesity After Subcutaneous Injection of Enoxaparin for Antithrombotic Prophylaxis at Two Different Sites' on Oct. 2.
Study Type: Observational
Primary Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Condition:
Venous Thromboembolism
Obese Patients
Recruitment Status: Not recruiting
Date of First Enrollment: October 1, 2025
Target Sample Size: 80
To know more, visit https://clinicaltrials.gov/study/NCT07213713
Published by HT Digital Content Services with permission from Health Daily Digest....